FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1177471000168109: Lignocaine (Claris) (lidocaine hydrochloride monohydrate 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use)

Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2634181000168114 Lignocaine (Claris) (lidocaine hydrochloride monohydrate 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2634191000168112 Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Is a Lignocaine (Claris) true Inferred relationship Some
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Is a trade product unit of use true Inferred relationship Some
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Is a lidocaine hydrochloride monohydrate 2% (100 mg/5 mL) injection, ampoule true Inferred relationship Some
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule has manufactured dose form injection true Inferred relationship Some
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule has unit of use ampoule true Inferred relationship Some 1273385198
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule has Australian BoSS lidocaine hydrochloride monohydrate true Inferred relationship Some 1273385197
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule has intended active ingredient lidocaine true Inferred relationship Some 1273385197
Inbound Relationships Type Active Source Characteristic Refinability Group
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules has TPUU True Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 x 5 mL ampoules has TPUU True Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 25 x 5 mL ampoules has TPUU True Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Lignocaine (Claris) (lidocaine hydrochloride monohydrate 100 mg / 5 mL) injection, 25 x 5 mL ampoules (containered trade product pack) has TPUU True Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Lignocaine (Claris) (lidocaine hydrochloride monohydrate 100 mg / 5 mL) injection, 5 x 5 mL ampoules (trade product pack) has TPUU True Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Lignocaine (Claris) 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules has TPUU True Lignocaine (Claris) 2% (100 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start